Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
Clinical characteristics and prognostic value of the KRAS mutation in Chinese colorectal cancer patients - Ye Yuan, Yingting Liu, Ye Wu, Junling Zhang, Chunti Shen, Feng Zhang, Changping Wu, Wenwei Hu, 2021
KRAS and extended RAS molecular profiling in metastatic colorectal cancer | Colorectal Cancer
Frequencies of KRAS mutations measured using methods with different... | Download Scientific Diagram
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports
Integrated multi-omics characterization of KRAS mutant colorectal cancer
,0.jpg "Progress towards individualized treatment of colorectal cancer UAB Barcelona")
Progress towards individualized treatment of colorectal cancer UAB Barcelona
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
Prevalence of KRAS, NRAS and BRAF mutations in patients with colorectal... | Download Scientific Diagram
Frontiers | Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer | BMC Cancer | Full Text
The Trouble With KRAS - Cancer Commons
BRAF Mutation in Colorectal Cancer | IntechOpen
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
RAS mutations: impact on treatment outcome | Colorectal Cancer
Targeting KRAS mutant cancers: from druggable therapy to drug resistance | Molecular Cancer | Full Text
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
:max_bytes(150000):strip_icc()/kras-g12c-mutation-in-nsclc-4843957-v3-456bf340786c481b857d044b6a8cb307-b4828f2507074811b94472745e488299.png "KRAS Positive Lung Cancer: Testing and Management")
KRAS Positive Lung Cancer: Testing and Management
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Targeting the untargetable KRAS in cancer therapy - ScienceDirect
KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy | Annals of Surgical Oncology
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer - ScienceDirect
Life | Free Full-Text | Integrated Decision-Making in the Treatment of Colon-Rectal Cancer: The Case of KRAS-Mutated Tumors
